MannKind | Utile Per Azione

Fiscal Calendario Efettivo Consenso Precedente Data
FY2024Q1 Mar/2024 0.03 -0.04 May/07 2024
FY2023Q4 Dec/2023 0.02 0.00 -0.07 Feb/27 2024
FY2023Q3 Sep/2023 0.02 -0.02 -0.06 Nov/07 2023
FY2023Q2 Jun/2023 -0.02 -0.04 -0.11 Aug/07 2023
FY2023Q1 Mar/2023 -0.04 -0.05 -0.1 May/09 2023
FY2022Q4 Dec/2022 -0.07 -0.06 -0.11 Feb/22 2023
FY2022Q3 Sep/2022 -0.06 -0.09 -0.02 Nov/08 2022
FY2022Q2 Jun/2022 -0.11 -0.10 -0.05 Aug/09 2022
FY2022Q1 Mar/2022 -0.1 -0.10 -0.05 May/05 2022
FY2021Q4 Dec/2021 -0.11 -0.07 -0.06 Feb/24 2022
FY2021Q3 Sep/2021 -0.02 -0.09 -0.05 Nov/09 2021
FY2021Q2 Jun/2021 -0.05 -0.04 -0.05 Aug/11 2021

Eps Cambiamento Data
Adma Biologics USD -0.08 0.09 2023-12
Dynavax Technologies USD 0.1 0.07 2023-09
Eli Lilly USD 2.49 2.39 2023-12
Halozyme Therapeutics USD 0.82 0.07 2023-12
Insmed USD -1.28 0.17 2023-12
MacroGenics USD -0.75 1.03 2023-12
MannKind USD 0.01 0.03 2023-09
Merck USD 0.03 2.1 2023-12
Novo Nordisk DKK 4.91 0.09 2023-12
Pfizer USD 0.1 0.27 2023-12
Sanofi EUR 1.66 0.89 2023-12
Xencor USD -0.31 0.09 2023-12



MannKind Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.